EUVIMEDEUVIMED entdecken
Open Access

Increased Myeloid-Derived Suppressor Cells in Newly Diagnosed Multiple Sclerosis: Immunophenotyping and Functional Validation

Nazire Pınar Acar Özen, Hamdullah Yanık, Aslı Tuncer

Archives of Neuropsychiatry · 2026

DOI: 10.29399/npa.29385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Neuropsychiatry, 2026. Verfasst von Nazire Pınar Acar Özen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hacettepe University Faculty of Medicine, Ankara, Türkiye. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Flow cytometryT-cell suppressionmultiple sclerosismyeloid derived suppressor cells

Autor:innen und Institutionen

  • Department of Neurology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
  • Hacettepe University Multiple Sclerosis Research and Application Center, Ankara, Türkiye.
  • Hacettepe University Cancer Institute, Department of Basic Oncology, Ankara, Türkiye.
  • University of Health Sciences, Gülhane Faculty of Medicine, Department of Medical Biology, Ankara, Türkiye.

Zitieren

APA

Özen, N. P. A., Yanık, H., & Tuncer, A. (2026). Increased Myeloid-Derived Suppressor Cells in Newly Diagnosed Multiple Sclerosis: Immunophenotyping and Functional Validation. Archives of Neuropsychiatry. https://doi.org/10.29399/npa.29385

Vancouver

Özen NPA, Yanık H, Tuncer A. Increased Myeloid-Derived Suppressor Cells in Newly Diagnosed Multiple Sclerosis: Immunophenotyping and Functional Validation. Archives of Neuropsychiatry. 2026. doi:10.29399/npa.29385

BibTeX
@article{zen2026,
  author = {Özen, Nazire Pınar Acar and Yanık, Hamdullah and Tuncer, Aslı},
  title = {Increased Myeloid-Derived Suppressor Cells in Newly Diagnosed Multiple Sclerosis: Immunophenotyping and Functional Validation},
  journal = {Archives of Neuropsychiatry},
  year = {2026},
  doi = {10.29399/npa.29385}
}
Kostenlos starten →